EPISODE · Oct 19, 2023 · 8 MIN
Thursday, October 19, 2023
from The Gist Healthcare Podcast
CMS has removed amyloid PET scan restrictions for Medicare beneficiaries. Novo Nordisk stops its Ozempic trial for treating kidney failure following early signs of the drug’s success. And, a new study finds that healthcare providers continue to leave the field in droves. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
CMS has removed amyloid PET scan restrictions for Medicare beneficiaries. Novo Nordisk stops its Ozempic trial for treating kidney failure following early signs of the drug’s success. And, a new study finds that healthcare providers continue to leave the field in droves. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Thursday, October 19, 2023
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m